Increased temporal dispersion of myocardial repolarization in myotonic dystrophy Type 1: Beyond the cardiac conduction system

International Journal of Cardiology

Volumn 156, Issue 3, 2012, Pages 259-264

  Magrì, Damiano ^a   Piccirillo, Gianfranco ^b   Bucci, Elisabetta ^a   Pignatelli, Giulia ^a   Cauti, Filippo Maria ^a   Morino, Stefania ^a   Latino, Pamela ^a   Santini, Daria ^a   Marrara, Federica ^a   Volpe, Massimo ^a,c   Antonini, Giovanni ^a   Testa, Marco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b POLICLINICO UMBERTO I   (Italy)

^c IRCCS NEUROMED   (Italy)

Author keywords

Autonomic nervous system; Heart rate variability; Myotonic dystrophy type 1; Power spectral analysis; QT variability; Ventricular arrhythmias

Indexed keywords

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSINE THYMINE GUANINE REPEAT; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FIRST DEGREE ATRIOVENTRICULAR BLOCK; HEART CONDUCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE VARIABILITY; HEART REPOLARIZATION; HEART VENTRICLE EXTRASYSTOLE; HOLTER MONITORING; HUMAN; MALE; MYOTONIC DYSTROPHY; MYOTONIC DYSTROPHY TYPE 1; NON INVASIVE MEASUREMENT; NUCLEOTIDE REPEAT; OBSERVATIONAL STUDY; PR INTERVAL; PRIORITY JOURNAL; QT VARIABILITY INDEX; RISK ASSESSMENT; SUPRAVENTRICULAR PREMATURE BEAT;

ADULT; ELECTROCARDIOGRAPHY; FEMALE; HEART CONDUCTION SYSTEM; HEART RATE; HUMANS; MALE; MIDDLE AGED; MYOTONIC DYSTROPHY; TIME FACTORS;

EID: 84859790219     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.10.132     Document Type: Article

References (46)

1. Mathieu J, Allard P, Potvin L, et al. A 10-years study of mortality in a cohort of patients with myotonic dystrophy. Neurology 1999;52:1658-62. (Pubitemid 29220644)
2. Harper PS, van Engelen BG, Eymard B, Rogers M, Wilcox D. 99th European Neuromuscular Centre International Workshop: myotonic dystrophy: present management, future therapy. Neuromuscol Disord 2002;12:596-9.
3. Harper PS. Myotonic dystrophy3rd Edition. 2001. London: WB Saunders; 2001.
4. Pelargonio G, Dello Russo A, Sanna T, De Martino G, Belloci F. Myotonic dystrophy and the heart. Heart 2002;88:665-70. (Pubitemid 35418097)
5. Lazarus A, Varin J, Babuty D, Anselme F, Coste J, Duboc D. Long-term follow-up of arrhythmias in patients with myotonic dystrophy treated by pacing: a multicenter diagnostic pace-maker study. J Am Coll Cardiol 2002;40:1645-52. (Pubitemid 35253643)
6. Antonini G, Giubilei F, Mammarella A, Amicucci P, Fiorelli M, Gragnani F, et al. Natural history of cardiac involvement in myotonic dystrophy: correlation with CTG repeats. Neurology 2000;55:1207-9.
7. Phillips MF, Harper PS. Cardiac disease in myotonic dystrophy. Cardiovasc Res 1997;33:13-22. (Pubitemid 27019094)
8. Merino JL, Carmona JR, Fernandez-Lozano I, Peinado R, Basrerra N, Sobrino JA. Mechanisms of sustained ventricular tachycardia in myotonic dystrophy. Circulation 1998;98:541-6.
9. Hadian D, Lowe MR, Scott LR, et al. Use of an insertable loop recorder in a myotonic dystrophy patient. J Cardiovasc Electrophysiol 2002;13:72-3. (Pubitemid 34113624)
10. Groh EJ, Lowe MR, Zipes DP, et al. Severity of cardiac conduction involvement and arrhythmias in myotonic dystrophy type 1. N Engl J Med 2008;358:2688-97.
11. Cudia P, Bernasconi P, Chiodelli R, Mangiola F, Bellocci F, Dello Russo A. Risk arrhythmias type I myotonic dystrophy role clinical genetic variables. J Neurol Neurosurg Psychiatry 2009;80:790-3.
12. Zipes DP, Wellens HJJ. Sudden cardiac death. Circulation 1998;98:2334-51. (Pubitemid 28533855)
13. Task force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standard of measurements, physiological interpretation and clinical use. Circulation 1996;93:1043-65.
14. Maison-Blanche P, Coumel P. Changes in repolarization dynamicity and the assessment of arrhythmic risk. Pacing Clin Electrophysiol 1997;20:2614-24.
15. Haigney MC, Zareba W, Gentlesk PJ, et al. QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II. J Am Coll Cardiol 2004;44:1481-7. (Pubitemid 39303953)
16. La Rovere MT, Pinna GD, Maestri R, et al. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation 2003;107:565-70. (Pubitemid 36176805)
17. Church S. The heart in myotonia atrophica. Arch Intern Med 1967;119:176-81.
18. Bhakta D, Lowe MR, Grow WJ. Prevalence of structural cardiac abnormalities in patients with myotonic dystrophy type I. Am Heart J 2004;147:224-7. (Pubitemid 38176820)
19. Aminoff MJ, Beckley DJ, McIlroy MB. Autonomic function in myotonic dystrophy. Arch Neurol 1985;42:16.
20. Inoue K, Ogata H, Matsui M, et al. Assessment of autonomic function in myotonic dystrophy by spectral analysis of heart rate variability. J Auton Nerv Syst 1995;55: 131-4.
21. Hardin BA, Lowe MR, Bhakta D, Groh WJ. Heart rate variability declines with increasing age and CTG repeat length in patients with myotonic dystrophy type 1. AN E 2003;8:227-32. (Pubitemid 38569981)
22. Berger RD, Kasper EK, Baughman KL, et al. Beat-to-beat QT interval variability. Novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy. Circulation 1997;96:1557-65.
23. Atiga WL, Calkins H, Lawrence JH, Tomaselli GF, Smith JM, Berger RD. Beat-to-beat repolarization lability identifies patients at risk for sudden cardiac death. Jl Cardiovasc Electrophysiol 1998;9:899-908. (Pubitemid 28455959)
24. Piccirillo G, Magrì D, Matera S, Marigliano V. Emotions that afflicts the heart: influence of the autonomic nervous system on temporal dispersion of myocardial repolarization. J Cardiovasc Electrophysiol 2008;19:185-7. (Pubitemid 351197981)
25. Piccirillo G, Magrì D, Matera S, et al. QT variability strongly predicts sudden cardiac death in asymptomatic subjects with mild or moderate left ventricular systolic dysfunction: a prospective study. Eur Heart J 2007;28:1344-50. (Pubitemid 47355965)
26. Fokstuen S, Myrin J, Evans C, et al. Presymptomatic testing in myotonic dystrophy: genetic counseling approaches. J Med Genet 2001;38:846-50. (Pubitemid 34014209)
27. Gennarelli M, Novelli G, Andreasi BF, et al. Prediction of myotonic dystrophy clinical severity based on the number of intragenic (CTG)n trinucleotide repeats. Am J Med Genet 1996;65:342-7.
28. Mathieu J, Boivin H, Meunier D, et al. Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy. Neurology 2001;56:336-40. (Pubitemid 32144144)
29. El-Omar M, Kardos A, Casadei B. Mechanism of respiratory sinus arrhythmia in patients with mild heart failure. AmJ Physiol Heart Circ Physiol 2001;280:H215-31.
30. Piccirillo G, Magrì D, Naso C, et al. Factor influencing HRV power spectral analysis during controlled breathing in patients with chronic heart failure or hypertension and in healthy normotensive subjects. Clin Sci 2004;107:183-90. (Pubitemid 39070935)
31. Piccirillo G, Ogawa M, Song J, et al. Power spectral analysis of heart rate variability and autonomic nervous system activity measured directly in healthy dogs and dogs with tachycardia-induced heart failure. Heart Rhythm 2009;6:546-52.
32. Tsilfidis C, Mackenzie AE, Mettler G, et al. Correlation between CTG trinucleotide repeat length and frequency of severe congenital myotonic dystrophy. Nat Genet 1992;1:192-5.
33. Magrì D, Sciomer S, Fedele F, et al. Increased QT variability in young asymptomatic patients with β-thalassemia major. Eur J Hematol 2007;79:322-9. (Pubitemid 47390133)
34. Piccirillo G, Magrì D, Mitra M, et al. Increased QT variability in cerebral autosomal dominant arteriopathy with Subcortical nfarcts and leukoencephalopathy (CADASIL). Eur J Neurol 2008;15:1216-21.
35. Piccirillo G, Magrì D, Ogawa M, et al. Autonomic nervous system activity measured directly and QT interval variability in normal and pacing-induced tachycardia heart failure dogs. J Am Coll Cardiol 2009;54:840-50.
36. Breton R, Mathieu J. Usefulness of clinical and electrocardiographic data for predicting adverse cardiac events in patients with myotonic dystrophy. Can J Cardiol 2009;25:e23-7.
37. Melacini P, Villanova C, Menegazzo E, et al. Correlation between cardiac involvement and CTG trinucleotide repeat length in myotonic dystrophy. J Am Coll Cardiol 1985;6:254-8.
38. Lindqvist P,Morner S, Olofsson BO, et al. Ventricular dysfunction in type 1myotonic dystrophy: electrical, mechanical, or both. Int J Cardiol 2010;134:195-200.
39. Di Cori A, Bongiorni MG, Zucchelli G, et al. Early ventricular structural myocardial alterations and their relationship with functional and electrical properties of the heart in myotonic dystrophy type 1. J Am Soc Echocardiogr 2009;22:1173-9.
40. Vignaux O, Lazarus A, Varin J, et al. Right ventricular MR abnormalities in myotonic dystrophy and relationship with intracardiac electrophysiological test findings: initial results. Radiology 2002;224:231-5. (Pubitemid 34685512)
41. Dello Russo A, Pelargonio G, Parisi Q, et al. Widespread electroanatomic alterations of right cardiac chambre in patients with myotonic dystrophy type 1. J Cardiovasc Electrophysiol 2006;17:34-40.
42. Nigro Ge, Nigro G, Politano L, et al. Is the value of QT dispersion a valid method to foresee the risk of sudden death? A study in Becker patients. Heart 2002;87:156-7.
43. Di Leo R, Rodolico C, De Gregorio C, et al. Cardiovascular autonomic control in myotonic dystrophy type 1: a correlative study with clinical and genetic data. Neuromuscul Disord 2004;14:136-41. (Pubitemid 38083322)
44. Casella M, Dello Russo A, Pace M, et al. Heart rate turbulence as a noninvasive risk predictor of ventricular tachyarrhythmias inmyotonic dystrophy type 1. J Cardiovasc Electrophysiol 2006;17:871-6. (Pubitemid 44079747)
45. Laurent V, Pellieux S, Corcia P, et al.Mortality inmyotonic dystrophy patients in the area of prophylactic pacing devices. Int J Cardiol 2010, doi:10.1016/j.ijcard.2010.02.029 [Epub ahead of print].
46. Coats AJ. Ethical authorship and publishing. Int J Cardiol 2009;131:149-50.